Paper39752109
Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.
Bhutta ZA and 1 other. Arch Pharm Res, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges. Papers, record 39752109. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39752109
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Disease Models, Animal | Major topic |
| Mammary Neoplasms, Animal | Major topic |
| Animals | |
| Dogs | |
| Humans | |
| Female |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022R1A4A1025557 | National Research Foundation (NRF) of Korea | PubMed | ||
| MOE | National Research Foundation (NRF) of Korea | PubMed | ||
| 2021RIS-001 | National Research Foundation (NRF) of Korea | PubMed |
Source PubMed
References153
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15141381 | Expression of luminal and basal cytokeratins in human breast carcinoma. | J Pathol | 2004 | https://conductscience.org/library/papers/15141381 | PubMed |
| 2 | 36978614 | National Dog Survey: Describing UK Dog and Ownership Demographics. | Animals (Basel) | 2023 | https://conductscience.org/library/papers/36978614 | PubMed |
| 3 | 29961579 | Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. | Cell | 2018 | https://conductscience.org/library/papers/29961579 | PubMed |
| 4 | 30514914 | Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. | Nat Commun | 2018 | https://conductscience.org/library/papers/30514914 | PubMed |
| 5 | 37283510 | GH and IGF1 in cancer therapy resistance. | Endocr Relat Cancer | 2023 | https://conductscience.org/library/papers/37283510 | PubMed |
| 6 | 11323501 | Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53. | Ann Surg | 2001 | https://conductscience.org/library/papers/11323501 | PubMed |
| 7 | 29394917 | Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29394917 | PubMed |
| 8 | 22847008 | Role of p63 in Development, Tumorigenesis and Cancer Progression. | Cancer Microenviron | 2012 | https://conductscience.org/library/papers/22847008 | PubMed |
| 9 | 28799073 | Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1. | Curr Oncol Rep | 2017 | https://conductscience.org/library/papers/28799073 | PubMed |
| 10 | 39533509 | Phytochemicals as Novel Therapeutics for Triple-Negative Breast Cancer: A Comprehensive Review of Current Knowledge. | Phytother Res | 2025 | https://conductscience.org/library/papers/39533509 | PubMed |
| 11 | 39345747 | Effect of punicalagin on the autophagic cell death in triple-negative breast cancer cells. | Toxicol Res | 2024 | https://conductscience.org/library/papers/39345747 | PubMed |
| 12 | 24138885 | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Immunity | 2013 | https://conductscience.org/library/papers/24138885 | PubMed |
| 13 | 31730395 | The Acidic Tumor Microenvironment as a Driver of Cancer. | Annu Rev Physiol | 2020 | https://conductscience.org/library/papers/31730395 | PubMed |
| 14 | 36768202 | Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768202 | PubMed |
| 15 | 30057419 | CD4+ T cell help in cancer immunology and immunotherapy. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/30057419 | PubMed |
| 16 | 36983412 | Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer. | J Clin Med | 2023 | https://conductscience.org/library/papers/36983412 | PubMed |
| 17 | 33208018 | p53, ER, and Ki67 Expression in Canine Mammary Carcinomas and Correlation With Pathological Variables and Prognosis. | Vet Pathol | 2021 | https://conductscience.org/library/papers/33208018 | PubMed |
| 18 | 22095586 | Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro. | J Cell Biochem | 2012 | https://conductscience.org/library/papers/22095586 | PubMed |
| 19 | 19945040 | The ACR BI-RADS experience: learning from history. | J Am Coll Radiol | 2009 | https://conductscience.org/library/papers/19945040 | PubMed |
| 20 | 32961915 | A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study. | Animals (Basel) | 2020 | https://conductscience.org/library/papers/32961915 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42798018 | p53 in Canine Mammary Tumors: From Molecular Pathogenesis to Biomarker Applications and Comparative Oncology. | Vet Sci | 2026 | https://conductscience.org/library/papers/42798018 | PubMed |
| 42620570 | PI3K over-expression drives canine mammary tumor progression. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42620570 | PubMed |
| 42510834 | Development of Autologous Dendritic Cell Vaccine Therapeutics for Canine Mammary Cancer. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42510834 | PubMed |
| 42509465 | FGFR4-associated APOBEC3 mutagenesis characterizes HER2-enriched subtype of human breast cancer. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42509465 | PubMed |
| 42454670 | Enhancing EGFR Inhibition: Monensin and Erlotinib Synergize to Eliminate Cancer Stem Cells in Canine Mammary Tumours. | Vet Comp Oncol | 2026 | https://conductscience.org/library/papers/42454670 | PubMed |
| 41012800 | Comparative Genetics of Canine and Human Cancers. | Vet Sci | 2025 | https://conductscience.org/library/papers/41012800 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39752109
GET https://conductscience.org/api/papers/v1/39752109/references?page=2